Skip to Main Content

Paper Details

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
5
2023
Cardiolovascular Disease, Women, cardiovascular disease, estrogen, menopausal symptoms, patients, progestin, women
Author NameAffiliation
Andrew M KaunitzUniversity of Florida College of Medicine-Jacksonville (A.M.K.).
Stephanie S FaubionMayo Clinic
Jan L ShifrenMassachusetts General Hospital
Cynthia A StuenkelUniversity of California, San Diego School of Medicine
  • 1 - 4

Datasets

Release 1.2